skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Bone Marrow Transplantation remover assunto: Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization
Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization

TRICOT, G ; COTTLER-FOX, M. H ; CALANDRA, G

Bone marrow transplantation (Basingstoke), 2010-01, Vol.45 (1), p.63-68 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients

FRUEHAUF, S ; EHNINGER, G ; HÜBEL, K ; TOPALY, J ; GOLDSCHMIDT, H ; HO, A. D ; MÜLLER, S ; MOOS, M ; BADEL, K ; CALANDRA, G

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.269-275 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

DUGAN, M. J ; MAZIARZ, R. T ; BENSINGER, W. I ; NADEMANEE, A ; LIESVELD, J ; BADEL, K ; DEHNER, C ; GIBNEY, C ; BRIDGER, G ; CALANDRA, G

Bone marrow transplantation (Basingstoke), 2010-01, Vol.45 (1), p.39-47 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor + G-CSF in adult patients with germ cell tumors
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor + G-CSF in adult patients with germ cell tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of hematopoietic stem cell remobilization with plerixafor + G-CSF in adult patients with germ cell tumors

HORWITZ, M. E ; LONG, G ; HOLMAN, P ; LIBBY, E ; CALANDRA, G. C ; SCHRIBER, J. R

Bone marrow transplantation (Basingstoke), 2012-10, Vol.47 (10), p.1283-1286 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and or cytokine treatment: compassionate use data
AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and or cytokine treatment: compassionate use data
Material Type:
Artigo 		Adicionar ao Meu Espaço

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and or cytokine treatment: compassionate use data

CALANDRA, G ; MCCARTY, J ; MCGUIRK, J ; TRICOT, G ; CROCKER, S.-A ; BADEL, K ; GROVE, B ; DYE, A ; BRIDGER, G

Bone marrow transplantation (Basingstoke), 2008-02, Vol.41 (4), p.331-338 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide

MICALLEF, Inm ; HO, A. D ; KLEIN, L. M ; MARULKAR, S ; GANDHI, P. J ; MCSWEENEY, P. A

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.350-355 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Rescue from failed growth factor and or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience
Rescue from failed growth factor and or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rescue from failed growth factor and or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

FOWLER, C. J ; DUNN, A ; MAZIARZ, R. T ; HAYES-LATTIN, B ; HANSEN, K ; HANSEN, L ; LANIER, K ; NELSON, V ; KOVACSOVICS, T ; LEIS, J ; CALANDRA, G

Bone marrow transplantation (Basingstoke), 2009-06, Vol.43 (12), p.909-917 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

HÜBEL, K ; FRESEN, M. M ; HEITS, F ; LORDICK, F ; RÖSLER, W ; WEHLER, D ; ZANDER, A. R ; ALBERT, M. H ; DRESSIER, S ; EBINGER, M ; FRICKHOFEN, N ; HERTENSTEIN, B ; SALWENDER, H ; KIEHL, M ; LIEBLER, S ; VON LILIENFELD-TOAL, M ; WEIDMANN, E ; WEIGELT, C ; LANGE, F ; KRÖGER, N ; BASARA, N ; BEIER, R ; THEURICH, S ; CHRISTOPEIT, M ; BOGNER, C ; GALM, O ; HARTWIG, R

Bone marrow transplantation (Basingstoke), 2011-08, Vol.46 (8), p.1045-1052 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization
Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization

Sánchez-Ortega, I ; Querol, S ; Encuentra, M ; Ortega, S ; Serra, A ; Sanchez-Villegas, J M ; Grifols, J R ; Pujol-Balaguer, M M ; Pujol-Bosch, M ; Martí, J M ; Garcia-Cerecedo, T ; Barba, P ; Sancho, J M ; Esquirol, A ; Sierra, J ; Duarte, R F

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.34-39 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation
Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation

van der Heiden, P L J ; Arbous, M S ; van Beers, E J ; van den Bergh, W M ; le Cessie, S ; Demandt, A M P ; Eefting, M ; Hess, C ; Kusadasi, N ; Marijt, W A F ; van Mook, W N K A ; Müller, M C A ; Tuinman, P R ; van Vliet, M ; van Westerloo, D J ; Blijlevens, N M A

Bone marrow transplantation (Basingstoke), 2019-03, Vol.54 (3), p.418-424 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.